>> 全站文章索引 >> 第29页:
  • Response styles among patients with minor depression and dysthymia in primary care - [College of Health Sciences, University of Texas at El Paso, 79902, USA. schmaling@utep.edu]
  • A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care - [Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK. cps@cpsresearch.co.uk]
  • Impact of pain on depression treatment response in primary care - [Regenstrief Institute and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. mbair@regenstrief.org]
  • Depressed Platelet Status in an Elderly Patient With Hemorrhagic Stroke After Thrombolysis for Acute Myocardial Infarction: Response - [Serebruany, Victor L.; Gurbel, Paul A.]
  • Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population - [STEWART, R.; PRINCE, M.; RICHARDS, M.; BRAYNE, C.; MANN, A.]
  • Predictors of Depression Among Family Caregivers of Stroke Survivors. - [Grant, Joan S.; Elliott, Timothy R.; Bartolucci, Alfred A.; Giger, Joyce N.]
  • A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction - [Aben, I.; Verhey, F.; Strik, J.; Lousberg, R.; Lodder, J.; Honig, A.]
  • Family Caregivers of Stroke Survivors: Characteristics of Caregivers at Risk for Depression - [Grant, Joan S.; Weaver, Michael; Elliott, Timothy R.; Bartolucci, Alfred A.; Giger, Joyce Newman]
  • Depression Among Caregivers of Stroke Survivors - [Berg, Anu Lic; Palomaki, Heikki M.; Lonnqvist, Jouko M.; Lehtihalmes, Matti Lic; Kaste, Markku M.]
  • Stroke Survivor and Caregiver Congruence of Depressive Symptom Appraisal: 61 - [Klinedinst, N. Jennifer; Blanton, Sarah; Wolf, Steven L.; Clark, Patricia C.]
  • Impact of Poststroke Depression on Healthcare Utilization by Veteran Stroke Patients: P476 - [Jia, Huanguang; Williams, Linda; Qin, Haijing; Ried, Douglas; Damush, Theresa; Reker, Dean; Young, Linda; Wang, Xinping; Duncan, Pamela]
  • The Impact of Poststroke Depression on Healthcare Use by Veterans With Acute Stroke - [Jia, Huanguang Ph; Damush, Teresa M.; Qin, Haijing M.; Ried, L. Douglas; Wang, Xinping Ph; Young, Linda J.; Williams, Linda S.]
  • A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance - [F. Ridout *, R. Meadows, S. Johnsen, I. Hindmarch AD:HPRU Medical Research Centre, University of Surrey, Egerton Road, Guildford GU2 7XP, UK]
  • Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients - [F Graziano1, R Bisonni2, V Catalano3, R Silva2, S Rovidati4, E Mencarini4, B Ferraro4, F Canestrari4, A M Baldelli3, A De Gaetano5, P Giordani3, E Testa1 and V Lai1]
  • Depression after cardiac transplant treated with interpersonal psychotherapy and paroxetine - [Mark Miller]
  • The treatment of depression prescribing patterns of antidepressants in primary care in the UK - [Donoghue JM, Tylee A.]
  • Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications - [Jerrell JM, McIntyre RS]
  • 米氮平在智利精神科中应用的自然研究 - [Kroeze Sandra]
  • 米氮平在墨西哥精神科中应用的自然研究 - [Harmsen Herben J]
  • 米氮平治疗住院抑郁症患者 - [Bailer U, Praschak-Rieder N, Pezawas L, Kasper S]
  • 丙咪嗪与米氮平对住院抑郁患者的疗效差异 - [Bruijn JA, Moleman P, Mulder PG, van den Broek WWE]
  • 米氮平复发与急性期疗效模式 - [Charlotte Kremer, M.D., Megan M. Smith, BA., Jonathan E. Alpert, M.D., Maurizio Fava, M.D]
  • 米氮平在抑郁症临床相关亚组中的疗效 - [Nutt DJ]
  • 米氮平与安慰剂治疗重症抑郁住院患者双盲对照研究 - [Vartiainen H, Leinonen E]
  • 米氮平对抑郁症相关症状的起效：米氮平与SSRI对照汇总资料的因子分析 - [Albert J. Schutte, M.D]
  • 米氮平对抑郁症伴发焦虑症状的起效速度 - [Ilse Van Hensbeek, M.D., Medical Service Department, NV Organon, Molenstraat 110, Oss 5340 BH, Nethe]
  • 米氮平与抗抑郁药的起效 - [Stuart A. Montgomery, M.D., Imperial College of London, PO Box 8751, London W13 8WH, United Kingdom;]
  • 重症抑郁中疗效的迅速起效：米氮平与帕罗西汀对照试验[壁报]。 米氮平的药理特性 - [Benkert O et al]
  • 米氮平对健康对象及抑郁患者皮质醇分泌的急性抑制 - [Gregor Laakmann, Cornelius Schule]
  • 米氮平对生长激素的效应 - [Laakmann G et al]
  • 过量服用米氮平试图自杀者无并发症 - [Holzbach R, Jahn H, Pajonk FG, Mahne C.]
  • 米氮平非致死性过量 - [Retz W, Maier S, Maris F, Rosler M]
  • 米氮平过量首例报告 - [Hoes MJ, Zeijpveld JH]
  • 米氮平过量时的安全性 - [Bremner JD, Wingard P, Walshe Th]
  • 重症抑郁的心血管变异性及丙咪嗪或米氮平(Org 3770)的效应 - [Tulen JH, Bruijn JA, de Man KJ, Pepplinkhuizen L, van den Meiracker AH, Man in]
  • 米氮平和利培酮在精神病人中无药物相互作用：一项预初研究 - [Loonen AJ, Doorschot CH, Oostelbos MC, Sitsen JM.]
  • 新型抗抑郁药与细胞色素P450系统：万拉法新、尼法唑酮和米氮平 - [Owen JR, Nemeroff CB]
  • SSRI引起性功能障碍后换用米氮平 - [Gelenberg AJ, Laukes C, McGahuey C, Okayli G, Moreno F, Zentner L, Delgado P.]
  • 服用米氮平的抑郁症门诊患者的性功能状况 - [Boyarsky BK.]
  • 米氮平治疗11例因选择性5羟色胺再摄取抑制剂所致性功能障碍而依从不良的患者 - [Koutouvidis N, Pratikakis M, Fotiadou A.]
  • 抗抑郁药所致的性功能障碍：综述、分类、治疗建议 - [Ellison JM.]
  • 抗抑郁药长期治疗相关的体重增加 - [Norman Sussman, M.D., Department of Psychiatry, new York University School of Medicine, New York, NY]
  • 体重增加与抗抑郁药 - [Fava M.]
  • 米氮平和氟西汀对伴发失眠的重症抑郁患者的睡眠持续性指标和日间多睡效应的对照研究：中期报告 - [Daniel P. McNally, Shannon A. Rodner, Jennifer L. Cornier. Psychiatry]
  • 米氮平对睡眠多导图变量的影响 - [Michel Schittecatte, M.D., Department of Psychiatry, Hopital Van Gogh, Rue de L]
  • 抗抑郁药治疗伴失眠的抑郁症 - [Thase ME.]
  • 通过互动电讯记录不同剂量米氮平对警觉性和睡眠的影响 - [Radkakishun FS, Bos J van den, Heijden BCJM van der, Roes KCB, O]
  • 米氮平药理特点与不良反应的关系 - [Nutt D]
  • 米氮平的耐受性和患者依从性 - [Roose SP.]
  • 抗抑郁药的药理学：选择性还是多重性？ - [Westenberg HG]
  • 米氮平对中枢去甲肾上腺素能和5羟色胺能神经传递的作用 - [de Boer T.]
  • 新型抗抑郁药的开发 - [Stimmel GL, Dopheide JA, Stahl SM.]
  • 米氮平：一种具有去甲肾上腺素能和特异性5-羟色胺能作用的抗抑郁药 - [Stimmel GL, Dopheide JA, Stahl SM.]
  • 米氮平口服片剂的药代动力学：高脂餐的影响 - [Cohen M, Panagides J, Timmer CJ, Huisman JA]
  • 新型抗抑郁药米氮平的在体5-HT 1A间接激动作用 - [Berendsen HH, Broekkamp CL]
  • 米氮平在抑郁症治疗中的临床优势 - [Burrows GD, Kremer CM]
  • 临床前资料的临床意义：模型化合物米氮平 - [Delbressine LP, Vos RM.]
  • 米氮平的药理特性 - [de Boer T.]
  • 新型抗抑郁药 - [Hartmann PM]
  • 米氮平通过阻断a2肾上腺素能和5-羟色胺2C受体，提高额叶皮质多巴胺能和皮质边缘系统肾上腺素能传递，但不提高5-羟色胺能传递：与西酞普兰对照研究 - [Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas J]
  • 抗抑郁药的基础药理，第1部分：抗抑郁药具有7种迥然不同的作用机制 - [Stahl SM]
  • 所有抗抑郁药都是一样的吗？ - [Moller HJ]
  • 抑郁症治疗新药：SNaRI、NaSSA和NaRI - [Kent JM.]
  • 肾上腺素受体敏感性可作为抑郁症的标记 - [Francoise Dumont, M.D., Robert Machowski, Ph.D., Eric Fontaine,]
  • 米氮平治疗重症抑郁综述 - [Holm KJ, Markham A]
  • 抑郁症治疗的新进展 - [Montgomery SA.]
  • 米氮平与安慰剂和阿米替林治疗重症抑郁随机双盲、疗效与安全性对照研究的荟萃分析 - [Stahl S, Zivkov M, Reimitz PE, Panagides J, Hoff W.]
  • 设计新一代的抗抑郁药 - [Pinder RM]
  • 抗抑郁药米氮平 - [Puzantian T]
  • 米氮平临床概述 - [Gorman JM.]
  • 米氮平汇总资料荟萃分析的综述 - [Kasper S.]
  • 米氮平安全性综述 - [Montgomery SA.]
  • 重度抑郁患者的药物治疗：米氮平与阿米替林对照疗效的荟萃分析 - [Kasper S, Zivkov M, Roes KCB, Pols AG]
  • 米氮平治疗抑郁症的风险效益评估 - [Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.]
  • 有关米氮平治疗伴焦虑症状的重症抑郁的8项随机双盲对照临床试验的荟萃分析 - [Fawcett J and Barkin RL]
  • 有单相抑郁的家庭中的睡眠电生理对照研究 - [D.E.Giles,D.J.Kupfer,A.J.Rush等]
  • 睡眠和抑郁症—精神生物学研究的结果综述 - [D.Riemann,M.Berger,U.Voderholzer]
  • 老年人中睡眠主诉和抑郁症：前瞻性队列研究 - [R.E.Roberts,S.J.Shema,G.A.Kaplan,et al.]
  • 在综合医院中失眠是心境障碍的标志吗? - [F.L.Rocha,C.Hara, C.V.Rodrigues等]
  • Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial - [Lenze EJ, Mulsant BH, Shear MK, Dew MA, Miller MD, Pollock BG, Houck P, Tracey B, Reynolds CF.]
  • Comparison of the Novel Antipsychotic Ziprasidone with Clozapine and Olanzapine: Inhibition of Dorsal Raphe Cell Firing and the Role of 5-HT1A Receptor Activation - [Jeffrey S Sprouse Ph.D, Linda S Reynolds MS, John P Braselton BS, Hans Rollema Ph.D and Stevin H Zorn Ph.D]
  • Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons - [Szabo ST, Blier P.]
  • Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine - [Paul D. Callaghan, Kirsten Farrand, Abdallah Salem, Patrick Hughes, Lynette C. Daws and Rodney J. Irvine]
  • Inflammation and the pathophysiology of work-related musculoskeletal disorders - [Barbe MF, Barr AE]
  • Discontinuation reactions associated with SSRIs - [Macdonald, Lynn]
  • Bipolar Depression in Primary in primary care-A hidden threat - [Lewis FT.]
  • Pharmacologic treatment of depression in late life - [Alastair J Flint]
  • Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy - [Jeffery A Lieberman1, Joel Greenhouse2, Robert M Hamer3, K Ranga Krishnan4, Charles B Nemeroff5, David V Sheehan6, Michael E Thase7 and Martin B Keller8]
  • Strain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test - [Carolina López-Rubalcava Ph.D and Irwin Lucki Ph.D]
  • Nicotinic acetylcholine receptors as targets for antidepressants - [R D Shytle1,2,3,4,5,6,7, A A Silver2,3, R J Lukas8, M B Newman1,6, D V Sheehan7 and P R Sanberg1,2,3,4,5,6,7]
  • The Effect of Early Poststressor Intervention with Sertraline on Behavioral Responses in an Animal Model of Post-Traumatic Stress Disorder - [Michael A Matar A1, Hagit Cohen1, Zeev Kaplan1 and Joseph Zohar2]
  • Factors associated with sexual dysfunction in men with HIV infection - [Richardson D, Lamba H, Goldmeier D, Nalabanda A, Harris JR.]
  • Regulatory Effects of Reboxetine Treatment Alone, or Following Paroxetine Treatment, on Brain Noradrenergic and Serotonergic Systems - [Georgianna G Gould1, Marie-Christine Pardon1, David A Morilak1 and Alan Frazer1,2]
  • Shifting emphasis from pharmacogenomics to theragnostics - [Vural Ozdemir, Bryn Williams-Jones, Stephen J Glatt, Ming T Tsuang, James B Lohr, Christopher Reist]
  • Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants - [Alicia M Weissman, Barcey T Levy, Arthur J Hartz, Suzanne Bentler, et al]
  • Nasal Wegener’s and skin sarcoid—a rare combination of two granulomatous diseases - [Kuttikat A, Saeed T, Chopra B, Chopra S, Chakravarty K.]
  • Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex - [Kazuhiko Nakayama]
  • Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus - [Jesús M. Míguez, Lucinda Paz-Vali?as, Isabel Míguez, Manuel Aldegunde]
  • Effects of Acute Tryptophan Depletion on Negative Symptoms and Smoking Topography in Nicotine-Dependent Schizophrenics and Nonpsychiatric Controls - [Brian Hitsman1, Bonnie Spring2,3, William Wolf3,4, Regina Pingitore2,3, John W Crayton3,5 and Donald Hedeker6]
  • Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines - [Tao Xie1, Liqiong Tong1, Michael W McLane1, George Hatzidimitriou1, Jie Yuan1, Una McCann2 and George Ricaurte1]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 [29] 30